Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis

Lee JS, Kim JH

Although hepatic stellate cells, which are liver specific pericytes, have been recognized within the vasculature of the sinusoid for more than one hundred years, the biology and function of these...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Entecavir Treatment in Hepatitis B Virus-related Decompensated Cirrhosis

Kim YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC

Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hemodynamic alterations in cirrhosis and portal hypertension

Kim MY, Baik SK, Lee SS

Portal hypertension (PHT) is associated with hemodynamic changes in intrahepatic, systemic, and portosystemic collateral circulation. Increased intrahepatic resistance and hyperdynamic circulatory alterations with expansion of collateral circulation play a central...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Entecavir Therapy for Patients with Hepatitis B Virus-related Decompensated Cirrhosis

Kim IS, Mun JI, Koo JH, Kang CJ, Bak JK, Cheong JY, Cho SW

BACKGROUND/AIMS: Entecavie (ETV) has a potent antiviral effect and low rates of resistance in hepatitis B virus (HBV) and is the first-line monotherapy in patients with HBV-related decompensated cirrhosis. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Hepatic Iron Deposition and Serum Iron Indices with Hepatic Inflammation and Fibrosis Stage in Nonalcoholic Fatty Liver Disease

Moon JH, Park SH, Oh KC, Jung JO, Shin WG, Kim JP, Kim KO, Park CH, Hahn T, Yoo KS, Kim JH, Kim DJ, Lee MS, Park CK, Jun SY

  • KMID: 772970
  • Korean J Gastroenterol.
  • 2006 Jun;47(6):432-439.
BACKGROUND/AIMS: Nonalcoholic steatohepatitis can develop from nonalcoholic fatty liver and progress to severe liver disease such as cirrhosis. The mechanism determining the progression from fatty liver to steatohepatitis is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adefovir Dipivoxil Alone or in Combination with Ongoing Lamivudine in Patients with Decompensated Liver Disease and Lamivudine-resistant Hepatitis B Virus

Kim KM, Choi WB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ

The purpose of this prospective study was to evaluate the efficacy and safety of adefovir dipivoxil with or without ongoing lamivudine in decompensated lamivudine-resistant chronic hepatitis B patients. Forty-six hepatitis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr